Modulation of fibroblast growth factor 19 expression by bile acids, meal replacement and energy drinks, milk, and coffee

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Styer, Amanda M ^a   Roesch, Stephen L ^a   Argyropoulos, George ^a,b  

^a WEIS CENTER FOR RESEARCH   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CAFFEINE; FIBROBLAST GROWTH FACTOR 19; LIPOPROTEIN; MESSENGER RNA; COFFEE; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR;

ARTICLE; COFFEE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY DRINK; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD; FRACTIONATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEAL; MILK; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; TUMOR CELL LINE; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; BILE ACIDS AND SALTS; CELL LINE; CELL LINE, TUMOR; COFFEE; ENERGY DRINKS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; MILK;

EID: 84923308597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085558     Document Type: Article

References (32)

1. Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, et al. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27: 3417-3428. (Pubitemid 46685217)
2. Wu X, Li Y (2009) Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis. Aging (Albany NY) 1: 1023-1027.
3. Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, et al. (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58: 250-259.
4. Tomlinson E, Fu L, John L, Hultgren B, Huang X, et al. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143: 1741-1747. (Pubitemid 34415889)
5. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425. (Pubitemid 46825496)
6. Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem 285: 5165-5170.
7. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145: 2594-2603. (Pubitemid 38686202)
8. Kir S, Beddow SA, Samuel VT, Miller P, Previs SF, et al. (2011) FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331: 1621-1624.
9. Lundasen T, Galman C, Angelin B, Rudling M (2006) Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 260: 530-536. (Pubitemid 44772372)
10. Wistuba W, Gnewuch C, Liebisch G, Schmitz G, Langmann T (2007) Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR. World J Gastroenterol 13: 4230-4235. (Pubitemid 47377162)
11. Miyata M, Hata T, Yamakawa H, Kagawa T, Yoshinari K, et al. (2012) Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19. J Steroid Biochem Mol Biol 132: 41-47.
12. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, et al. (2008) Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 8: 77-83.
13. Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72: 137-174.
14. Chiang JY (2009) Bile acids: regulation of synthesis. J Lipid Res 50: 1955-1966.
15. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, et al. (2013) A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass. Diabetes Care 36: 1859-1864.
16. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, et al. (2012) The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153: 3613-3619.
17. Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, et al. (2013) Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97: 155-166.
18. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, et al. (2011) Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 10: 93.
19. van Dam RM, Willett WC, Manson JE, Hu FB (2006) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29: 398-403. (Pubitemid 44106525)
20. Gerhard GS, Styer AM, Strodel WE, Roesch SL, Yavorek A, et al. (2013) Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity. Int J Obes (Lond).
21. Wu X, Ge H, Lemon B, Vonderfecht S, Baribault H, et al. (2010) Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc Natl Acad Sci U S A 107: 14158-14163.
22. Ge H, Baribault H, Vonderfecht S, Lemon B, Weiszmann J, et al. (2012) Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolism. PLoS One 7: e33603.
23. Adams AC, Coskun T, Rovira AR, Schneider MA, Raches DW, et al. (2012) Fundamentals of FGF19 & FGF21 action in vitro and in vivo. PLoS One 7: e38438.
24. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, et al. (2013) A role for FGF19 and bile acids in the remission of type 2 diabetes. Diabetes Care In press.
25. Zhang JH, Nolan JD, Kennie SL, Johnston IM, Dew T, et al. (2013) Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am J Physiol Gastrointest Liver Physiol 304: G940-948.
26. Keogh JB, Clifton PM (2012) Meal replacements for weight loss in type 2 diabetes in a community setting. J Nutr Metab 2012: 918571.
27. Foster GD, Wadden TA, Lagrotte CA, Vander Veur SS, Hesson LA, et al. (2013) A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutr Diabetes 3: e63.
28. Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, et al. (2009) One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) 17: 713-722.
29. Cheng B, Liu X, Gong H, Huang L, Chen H, et al. (2011) Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus. J Agric Food Chem 59: 13147-13155.
30. Olthof MR, van Dijk AE, Deacon CF, Heine RJ, van Dam RM (2011) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr Metab (Lond) 8: 10.
31. Muley A, Muley P, Shah M (2012) Coffee to reduce risk of type 2 diabetes?: a systematic review. Curr Diabetes Rev 8: 162-168.
32. Zhang W, Lopez-Garcia E, Li TY, Hu FB, van Dam RM (2009) Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care 32: 1043-1045.